Volume 31, Issue 148 (September & October 2023)                   J Adv Med Biomed Res 2023, 31(148): 457-463 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rahimi R, Hajihossein R, Eslamirad Z. Anti-Acanthamoeba Potential of Valproate Sodium; an In Vitro Study. J Adv Med Biomed Res 2023; 31 (148) :457-463
URL: http://journal.zums.ac.ir/article-1-6892-en.html
Anti-Acanthamoeba Potential of Valproate Sodium; an In Vitro Study
Reza Rahimi1 , Reza Hajihossein2 , Zahra Eslamirad * 3
1- Dept. of Pharmacology, School of Medicine, Arak University of Medical Sciences, Arak, Iran
2- Dept. of Parasitology and Mycology, School of Medicine, Arak University of Medical Sciences, Arak, Iran
3- Dept. of Parasitology and Mycology, School of Medicine, Arak University of Medical Sciences, Arak, Iran , dr.eslami@arakmu.ac.ir
Abstract:   (1271 Views)

Background and Objective: Conventional treatment of Acanthamoeba typically involves a combination drug strategy, but its efficacy in clinical settings remains incomplete. Evaluating the therapeutic potential of existing drugs is a way used to introduce effective treatments for infectious agents. This study aimed to assess the in vitro anti-Acanthamoeba effect of valproate (VPA).
Materials and Methods: An experimental study was conducted using Acanthamoeba cysts belonging to the T4 and T5 genotypes. Cysts collected from the culture medium were exposed to gentamicin, polymyxin, and three different concentrations of VPA for varying durations (1, 4, 6, and 24 hours). The treated cysts were stained with trypan blue, and the percentage of growth inhibition was calculated. Additionally, the viability of treated cysts was assessed by culturing them on non-nutrient agar plates for one month.
Results: The Acanthamoeba cysts of T4 and T5 genotypes showed susceptibility to VPA. The minimal cysticidal concentration (MCC) of VPA for maximum growth inhibition in both single and combination drug assays were 100 and 3 mg/ml, for durations of 24 and 4 hours, respectively. The growth inhibition observed in the groups exposed to gentamicin and polymyxin differed significantly from the growth inhibition in the group treated with ≥100 mg/ml VPA (P< 0.05).
Conclusion: VPA enhances the effects of gentamicin and polymyxin on Acanthamoeba. Combining a low concentration of VPA (≥3 mg/ml) with gentamicin and polymyxin increases the potency and speed of action of these antibiotics.

Keywords: Acanthamoeba, Gentamicin, Polymyxin, Valproate, Single Drug Strategy, Combination Drug Strategy
Full-Text [PDF 576 kb]   (794 Downloads) |   |   Full-Text (HTML)  (395 Views)  

✅ VPA enhances the effects of gentamicin and polymyxin on Acanthamoeba. Combining a low concentration of VPA (≥3 mg/ml) with gentamicin and polymyxin increases the potency and speed of action of these antibiotics.


Type of Study: Original Article | Subject: Pharmacology
Received: 2022/07/23 | Accepted: 2022/10/28 | Published: 2023/10/29
References
1. Siddiqui R, Khan NA. Biology and pathogenesis of Acanthamoeba. Parasit Vectors. 2012;5(1):6. [DOI:10.1186/1756-3305-5-6]
2. Lasjerdi Z, Niyyati M, Lorenzo-Morales J, Haghighi A, Taghipour N. Ophthalmology hospital wards contamination to pathogenic free living Amoebae in Iran. Acta Parasitol. 2015;60(3):417-22. [DOI:10.1515/ap-2015-0057] [PMID]
3. Elsheikha HM, Siddiqui R, Khan NA. Drug discovery against Acanthamoeba infections: Present knowledge and unmet needs. Pathogens. 2020;9(5):405. [DOI:10.3390/pathogens9050405] [PMID] [PMCID]
4. Wei C, Yeng C, Mahboob T, et al. Natural products: Alternative therapeutic compounds against Acanthamoeba spp. Asian J Phamacogn. 2020;3(2):29-38.
5. Mitsuwan W, Sin C, Keo S, et al. Potential anti-Acanthamoeba and anti-adhesion activities of Annona muricata and Combretum trifoliatum extracts and their synergistic effects in combination with chlorhexidine against Acanthamoeba triangularis trophozoites and cysts. Heliyon. 2021;7(5):e06976. [DOI:10.1016/j.heliyon.2021.e06976] [PMID] [PMCID]
6. Thongseesuksai T, Wongwai P, Boonmars T, Sanpool O, Laummaunwai P. Evaluating the in vitro efficacy of gatifloxacin, levofloxacin and gentamicin against Acanthamoeba cysts. Int Ophthalmol. 2020;40(2):361-8. [DOI:10.1007/s10792-019-01188-4] [PMID]
7. Siddiqui R, Aqeel Y, Khan NA. The development of drugs against Acanthamoeba infections. Antimicrob Agents Chemother. 2016;60(11):6441-50. [DOI:10.1128/AAC.00686-16] [PMID] [PMCID]
8. Poolchanuan P, Unagul P, Thongnest S, et al. An anticonvulsive drug, valproic acid (valproate), has effects on the biosynthesis of fatty acids and polyketides in microorganisms. Sci Rep. 2020;10(1):9300. [DOI:10.1038/s41598-020-66251-y] [PMID] [PMCID]
9. Esiobu N, Hoosein N. An assessment of the in vitro antimicrobial effects of two antiepileptic drugs--sodium valproate and phenytoin. Antonie van Leeuwenhoek. 2003;83(1):63-8. [DOI:10.1023/A:1022992224594] [PMID]
10. Elbadawi MAA, Awadalla MKA, Hamid MMA, Mohamed MA, Awad TA. Valproic acid as a potential inhibitor of Plasmodium falciparum histone deacetylase 1 (PfHDAC1): an in silico approach. Int J Mol Sci. 2015;16(2):3915-31. [DOI:10.3390/ijms16023915] [PMID] [PMCID]
11. Chu KB, Lee HA, Pflieger M, et al. Antiproliferation and antiencystation effect of class II histone deacetylase inhibitors on Acanthamoeba castellanii. ACS Infect Dis. 2022;8(2):271-9. [DOI:10.1021/acsinfecdis.1c00390] [PMID]
12. Meighani M, Eslamirad Z, Hajihossein R, Ahmadi AS. Isolation and genotyping of Acanthamoeba from soil samples in Markazi province, Iran. Open Access Maced J Med Sci. 2018;6. [DOI:10.3889/oamjms.2018.454] [PMID] [PMCID]
13. Kamiloglu S, Sari G, Ozdal T, Capanoglu E. Guidelines for cell viability assays. Food Frontiers. 2020;1(3):332-49. [DOI:10.1002/fft2.44]
14. Seal D. Treatment of Acanthamoeba keratitis. Expert Rev Anti Infect Ther. 2003;1(2):205-8. [DOI:10.1586/14787210.1.2.205] [PMID]
15. Niederkorn JY. The biology of Acanthamoeba keratitis. Exp Eye Res. 2021;202:108365. [DOI:10.1016/j.exer.2020.108365] [PMID] [PMCID]
16. Mishra MK, Kukal S, Paul PR, Bora et al. Insights into structural modifications of valproic acid and their pharmacological profile. Molecules. 2022;27(1):104. [DOI:10.3390/molecules27010104] [PMID] [PMCID]
17. Romoli M, Mazzocchetti P, D'Alonzo R, et al. Valproic acid and epilepsy: From molecular mechanisms to clinical evidences. Curr Neuropharmacol. 2019;17(10):926-46. [DOI:10.2174/1570159X17666181227165722] [PMID] [PMCID]
18. Heers H, Stanislaw J, Harrelson J, Lee MW. Valproic acid as an adjunctive therapeutic agent for the treatment of breast cancer. Eur J pharmacol. 2018;835:61-74. [DOI:10.1016/j.ejphar.2018.07.057] [PMID]
19. Patel MM, Patel BM. Repurposing of sodium valproate in colon cancer associated with diabetes mellitus: Role of HDAC inhibition. Eur J pharm sci. 2018;121:188-99. [DOI:10.1016/j.ejps.2018.05.026] [PMID]
20. Fond G, Macgregor A, Tamouza R, et al. Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate. Eur Arch Psychiatry Clin Neurosci. 2014;264(2):179-83. [DOI:10.1007/s00406-013-0413-4] [PMID]
21. Abdullah N, Kamel AG, Anisah N, Noraina AR, Yusof S. The effectiveness of gentamicin against Acanthamoeba cysts in vitro. Malaysian J Med Health Sci. 2012;8:51-4.
22. Abd Ghani MK, Tang S, Nordin A, Hashim P, Suboh Y, Rahim N. In vitro susceptibility test for Acanthamoeba species isolated from clinical specimens against chlorhexidine, propamidine isethionate, gentamicin and chloramphenicol. Int Med J. 2011;18:147-9.
23. Hajihossein R, Eslamirad Z, Rafiei F, Naderi G, Assadi M. Anti-Acanthamoeba effect of Camellia sinensis extract (black and green tea) in vitro. J Med Plants. 2020;19(73):163-9. [DOI:10.29252/jmp.1.73.163]
24. Shing B, Balen M, McKerrow JH, Debnath A. Acanthamoeba Keratitis: An update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs. Expert Rev Anti Infect Ther. 2021;19(11):1427-41. [DOI:10.1080/14787210.2021.1924673] [PMID] [PMCID]
25. Sangkanu S, Mitsuwan W, Mahabusarakam W, et al. Anti-Acanthamoeba synergistic effect of chlorhexidine and Garcinia mangostana extract or α-mangostin against Acanthamoeba triangularis trophozoite and cyst forms. Sci Rep. 2021;11(1):1-11. [DOI:10.1038/s41598-021-87381-x] [PMID] [PMCID]
26. Alsarra I, Al-Omar M, Belal F. Valproic acid and sodium valproate: Comprehensive profile. Profile Drug Subst Excip Related Methodol. 2005;32:209-40. [DOI:10.1016/S0099-5428(05)32008-9] [PMID]
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb